Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.
Morse, Michael A
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. [electronic resource] - Cancer investigation Jun 2003 - 341-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0735-7907
10.1081/cnv-120018224 doi
Adult
Aged
Carcinoembryonic Antigen--adverse effects
Colonic Neoplasms--pathology
Dendritic Cells--physiology
Dose-Response Relationship, Drug
Female
Humans
Immunotherapy--methods
Leukapheresis
Liver Neoplasms--secondary
Male
Middle Aged
RNA, Messenger--genetics
Recombinant Proteins--therapeutic use
Survival Analysis
Transfection--methods
Transplantation, Autologous--adverse effects
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. [electronic resource] - Cancer investigation Jun 2003 - 341-9 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0735-7907
10.1081/cnv-120018224 doi
Adult
Aged
Carcinoembryonic Antigen--adverse effects
Colonic Neoplasms--pathology
Dendritic Cells--physiology
Dose-Response Relationship, Drug
Female
Humans
Immunotherapy--methods
Leukapheresis
Liver Neoplasms--secondary
Male
Middle Aged
RNA, Messenger--genetics
Recombinant Proteins--therapeutic use
Survival Analysis
Transfection--methods
Transplantation, Autologous--adverse effects